Works by Kebir, Sied

Results: 43

Are we providing best-available care to newly diagnosed glioblastoma patients? Systematic review of phase III trials in newly diagnosed glioblastoma 2005–2022.

Published in:

Neuro-Oncology Advances, 2023, v. 5, n. 1, p. 1, doi. 10.1093/noajnl/vdad105

By:

Oster, Christoph;
Schmidt, Teresa;
Agkatsev, Sarina;
Lazaridis, Lazaros;
Kleinschnitz, Christoph;
Sure, Ulrich;
Scheffler, Björn;
Kebir, Sied;
Glas, Martin

Publication type:

Article

Feasibility and tolerability of trofosfamide and etoposide in progressive glioblastoma.

Published in:

Neuro-Oncology Advances, 2023, v. 5, n. 1, p. 1, doi. 10.1093/noajnl/vdad090

By:

Schmidt, Teresa;
Agkatsev, Sarina;
Feldheim, Jonas;
Oster, Christoph;
Blau, Tobias;
Sure, Ulrich;
Keyvani, Kathy;
Kleinschnitz, Christoph;
Stuschke, Martin;
Herrmann, Ken;
Deuschl, Cornelius;
Scheffler, Björn;
Kebir, Sied;
Glas, Martin;
Lazaridis, Lazaros

Publication type:

Article

Telemedicine in Neuro-Oncology—An Evaluation of Remote Consultations during the COVID-19 Pandemic.

Published in:

Cancers, 2023, v. 15, n. 16, p. 4054, doi. 10.3390/cancers15164054

By:

Feldheim, Jonas;
Schmidt, Teresa;
Oster, Christoph;
Feldheim, Julia;
Stuschke, Martin;
Stummer, Walter;
Grauer, Oliver;
Scheffler, Björn;
Hagemann, Carsten;
Sure, Ulrich;
Kleinschnitz, Christoph;
Lazaridis, Lazaros;
Kebir, Sied;
Glas, Martin

Publication type:

Article

How about Levetiracetam in Glioblastoma? An Institutional Experience and Meta-Analysis.

Published in:

Cancers, 2021, v. 13, n. 15, p. 3770, doi. 10.3390/cancers13153770

By:

Jabbarli, Ramazan;
Ahmadipour, Yahya;
Rauschenbach, Laurèl;
Santos, Alejandro N.;
Darkwah Oppong, Marvin;
Pierscianek, Daniela;
Quesada, Carlos M.;
Kebir, Sied;
Dammann, Philipp;
Guberina, Nika;
Scheffler, Björn;
Kaier, Klaus;
Stuschke, Martin;
Sure, Ulrich;
Wrede, Karsten H.

Publication type:

Article

A Preliminary Study on Machine Learning-Based Evaluation of Static and Dynamic FET-PET for the Detection of Pseudoprogression in Patients with IDH-Wildtype Glioblastoma.

Published in:

Cancers, 2020, v. 12, n. 11, p. 3080, doi. 10.3390/cancers12113080

By:

Kebir, Sied;
Schmidt, Teresa;
Weber, Matthias;
Lazaridis, Lazaros;
Galldiks, Norbert;
Langen, Karl-Josef;
Kleinschnitz, Christoph;
Hattingen, Elke;
Herrlinger, Ulrich;
Lohmann, Philipp;
Glas, Martin

Publication type:

Article

Prognostic factors in recurrent glioblastoma patients treated with bevacizumab.

Published in:

Journal of Neuro-Oncology, 2016, v. 129, n. 1, p. 93, doi. 10.1007/s11060-016-2144-7

By:

Schaub, Christina;
Tichy, Julia;
Schäfer, Niklas;
Franz, Kea;
Mack, Frederic;
Mittelbronn, Michel;
Kebir, Sied;
Thiepold, Anna-Luisa;
Waha, Andreas;
Filmann, Natalie;
Banat, Mohammed;
Fimmers, Rolf;
Steinbach, Joachim;
Herrlinger, Ulrich;
Rieger, Johannes;
Glas, Martin;
Bähr, Oliver

Publication type:

Article

Regorafenib in glioblastoma recurrence: how to deal with conflicting 'real-life' experiences?

Published in:

2019

By:

Glas, Martin;
Kebir, Sied

Publication type:

Letter

Tlr2 deficiency does not limit the development of left ventricular hypertrophy in a model of transverse aortic constriction induced pressure overload.

Published in:

Journal of Negative Results in Biomedicine, 2016, v. 15, p. 1, doi. 10.1186/s12952-016-0050-3

By:

Tippaporn Bualeong;
Kebir, Sied;
Hof, Dorothea;
Goelz, Lina;
Graewe, Mathias;
Ehrentraut, Stefan Felix;
Knuefermann, Pascal;
Baumgarten, Georg;
Meyer, Rainer;
Ehrentraut, Heidi

Publication type:

Article

L-RNA aptamer-based CXCL12 inhibition combined with radiotherapy in newly-diagnosed glioblastoma: dose escalation of the phase I/II GLORIA trial.

Published in:

Nature Communications, 2024, v. 15, n. 1, p. 1, doi. 10.1038/s41467-024-48416-9

By:

Giordano, Frank A.;
Layer, Julian P.;
Leonardelli, Sonia;
Friker, Lea L.;
Turiello, Roberta;
Corvino, Dillon;
Zeyen, Thomas;
Schaub, Christina;
Müller, Wolf;
Sperk, Elena;
Schmeel, Leonard Christopher;
Sahm, Katharina;
Oster, Christoph;
Kebir, Sied;
Hambsch, Peter;
Pietsch, Torsten;
Bisdas, Sotirios;
Platten, Michael;
Glas, Martin;
Seidel, Clemens

Publication type:

Article

Simultaneous primary cancer occurrence of melanoma and pulmonary adenocarcinoma in leptomeningeal metastases: a case report.

Published in:

2019

By:

Stoppek, Ann-Kathrin;
Kebir, Sied;
Junker, Andreas;
Keyvani, Kathy;
Zülow, Stefan;
Lazaridis, Lazaros;
Schmidt, Teresa;
Pierscianek, Daniela;
Stuschke, Martin;
Sure, Ulrich;
Kleinschnitz, Christoph;
Scheffler, Björn;
Zimmer, Lisa;
Glas, Martin

Publication type:

journal article

[68Ga]‑DOTA‑conjugated somatostatin receptor‑targeting peptide PET for the differentiation between meningioma and glioblastoma: A case report and review of the literature.

Published in:

Oncology Letters, 2025, v. 29, n. 4, p. N.PAG, doi. 10.3892/ol.2025.14945

By:

Rauschenbach, Laurèl;
Gerach, Felix M.;
Berliner, Christoph;
Blau, Tobias;
Kebir, Sied;
Dobersalske, Celia;
Deuschl, Cornelius;
Sure, Ulrich;
Herrmann, Ken;
Dammann, Philipp

Publication type:

Article

18F-fluoroethyl-L-tyrosine positron emission tomography-guided diagnosis of a malignant intramedullary spinal cord tumor.

Published in:

Oncology Letters, 2016, v. 12, n. 6, p. 4705, doi. 10.3892/ol.2016.5234

By:

KEBIR, SIED;
KIMMICH, OKKA;
NIEHUSMANN, PITT;
GAERTNER, FLORIAN C.;
ESSLER, MARKUS;
LANDSBERG, JENNIFER;
KLOCKGETHER, THOMAS;
SIMON, MATTHIAS;
HERRLINGER, ULRICH;
GLAS, MARTIN

Publication type:

Article

18F-fluoroethyl-L-tyrosine positron emission tomography for the differential diagnosis of tumefactive multiple sclerosis versus glioma: A case report.

Published in:

2016

By:

KEBIR, SIED;
GAERTNER, FLORIAN C.;
MUELLER, MARCUS;
NELLES, MICHAEL;
SIMON, MATTHIAS;
SCHÄFER, NIKLAS;
STUPLICH, MORITZ;
SCHAUB, CHRISTINA;
NIESSEN, MICHAEL;
MACK, FREDERIC;
BUNDSCHUH, RALPH;
GRESCHUS, SUSANNE;
ESSLER, MARKUS;
GLAS, MARTIN;
HERRLINGER, ULRICH

Publication type:

Case Study

Gender disparity regarding work-life balance satisfaction among German neuro-oncologists: a YoungNOA survey.

Published in:

Neuro-Oncology, 2022, v. 24, n. 9, p. 1609, doi. 10.1093/neuonc/noac114

By:

Kebir, Sied;
Lazaridis, Lazaros;
Wick, Wolfgang;
Platten, Michael;
Tabatabai, Ghazaleh;
Combs, Stephanie E;
Schmidt, Teresa;
Agkatsev, Sarina;
Blau, Tobias;
Mäurer, Irina;
Kahlert, Ulf;
Sagerer, Andre;
Berberich, Anne;
Heider, Sina;
Müther, Michael;
Bodensohn, Raphael;
Behling, Felix

Publication type:

Article

INNV-23. SAFETY AND ADVERSE EVENT PROFILE OF TUMOR TREATING FIELDS IN ELDERLY PATIENTS A POST-MARKET SURVEILLANCE ANALYSIS.

Published in:

Neuro-Oncology, 2018, v. 20, p. vi143, doi. 10.1093/neuonc/noy148.596

By:

Shi, Wenyin;
Kebir, Sied;
Glas, Martin

Publication type:

Article

INNV-03. SAFETY AND ADVERSE EVENT PROFILE OF TUMOR TREATING FIELDS USE IN THE EMEA REGION A REAL-WORLD DATA ANALYSIS.

Published in:

Neuro-Oncology, 2018, v. 20, p. vi138, doi. 10.1093/neuonc/noy148.578

By:

Kebir, Sied;
Glas, Martin

Publication type:

Article

HOUT-30. TUMOR TREATING FIELDS (TTFIELDS) IN COMBINATION WITH LOMUSTINE (CCNU) AND TEMOZOLOMIDE (TMZ) IN PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA (GBM).

Published in:

Neuro-Oncology, 2018, v. 20, p. vi119, doi. 10.1093/neuonc/noy148.498

By:

Lazaridis, Lazaros;
Schäfer, Niklas;
Kebir, Sied;
Weller, Johannes;
Tzaridis, Theophilos-Dimitrios;
Scheffler, Björn;
Pierscianek, Daniela;
Kleinschnitz, Christoph;
Stuschke, Martin;
Sure, Ulrich

Publication type:

Article

Dynamic O-(2-[18F]fluoroethyl)- L-tyrosine PET imaging for the detection of checkpoint inhibitorrelated pseudoprogression in melanoma brain metastases.

Published in:

Neuro-Oncology, 2016, v. 18, n. 10, p. 1462, doi. 10.1093/neuonc/now154

By:

Kebir, Sied;
Rauschenbach, Laurèl;
Galldiks, Norbert;
Schlaak, Max;
Hattingen, Elke;
Landsberg, Jennifer;
Bundschuh, Ralph A.;
Langen, Karl-Josef;
Scheffler, Björn;
Herrlinger, Ulrich;
Glas, Martin

Publication type:

Article

MGMT promoter methylation analysis for allocating combined CCNU/TMZ chemotherapy: Lessons learned from the CeTeG/NOA‐09 trial.

Published in:

International Journal of Cancer, 2021, v. 148, n. 7, p. 1695, doi. 10.1002/ijc.33363

By:

Tzaridis, Theophilos;
Schäfer, Niklas;
Weller, Johannes;
Steinbach, Joachim‐Peter;
Schlegel, Uwe;
Seidel, Sabine;
Sabel, Michael;
Hau, Peter;
Seidel, Clemens;
Krex, Dietmar;
Goldbrunner, Roland;
Tonn, Jörg‐Christian;
Grauer, Oliver;
Kebir, Sied;
Schneider, Matthias;
Schaub, Christina;
Vatter, Hartmut;
Coch, Christoph;
Glas, Martin;
Fimmers, Rolf

Publication type:

Article

Longitudinal heterogeneity in glioblastoma: moving targets in recurrent versus primary tumors.

Published in:

2019

By:

Schäfer, Niklas;
Gielen, Gerrit H.;
Rauschenbach, Laurèl;
Kebir, Sied;
Till, Andreas;
Reinartz, Roman;
Simon, Matthias;
Niehusmann, Pitt;
Kleinschnitz, Christoph;
Herrlinger, Ulrich;
Pietsch, Torsten;
Scheffler, Björn;
Glas, Martin

Publication type:

journal article

Carmustine (BCNU) plus Teniposide (VM26) in Recurrent Malignant Glioma.

Published in:

Oncology, 2014, v. 86, n. 5/6, p. 369, doi. 10.1159/000360295

By:

Mack, Frederic;
Schäfer, Niklas;
Kebir, Sied;
Stuplich, Moritz;
Schaub, Christina;
Niessen, Michael;
Scheffler, Björn;
Herrlinger, Ulrich;
Glas, Martin

Publication type:

Article

FLAIR-Only Progression in Bevacizumab-Treated Relapsing Glioblastoma Does Not Predict Short Survival.

Published in:

Oncology, 2013, v. 85, n. 3, p. 191, doi. 10.1159/000354692

By:

Schaub, Christina;
Greschus, Susanne;
Seifert, Mirko;
Waha, Andreas;
Blasius, Elias;
Rasch, Katja;
Landwehr, Christiane;
Mack, Frederic;
Schäfer, Niklas;
Stuplich, Moritz;
Kebir, Sied;
Vilz, Belinda;
Scheffler, Björn;
Boström, Jan;
Simon, Matthias;
Urbach, Horst;
Glas, Martin;
Herrlinger, Ulrich

Publication type:

Article

Quantitative T1-mapping detects cloudy-enhancing tumor compartments predicting outcome of patients with glioblastoma.

Published in:

Cancer Medicine, 2017, v. 6, n. 1, p. 89, doi. 10.1002/cam4.966

By:

Müller, Andreas;
Jurcoane, Alina;
Kebir, Sied;
Ditter, Philip;
Schrader, Felix;
Herrlinger, Ulrich;
Tzaridis, Theophilos;
Mädler, Burkhard;
Schild, Hans H.;
Glas, Martin;
Hattingen, Elke

Publication type:

Article

Predictors and surgical outcome of hemorrhagic metastatic brain malignancies.

Published in:

Journal of Neuro-Oncology, 2024, v. 169, n. 1, p. 165, doi. 10.1007/s11060-024-04714-2

By:

Rauschenbach, Laurèl;
Kolbe, Pia;
Engel, Adrian;
Ahmadipour, Yahya;
Oppong, Marvin Darkwah;
Santos, Alejandro N.;
Kebir, Sied;
Dobersalske, Celia;
Scheffler, Björn;
Deuschl, Cornelius;
Dammann, Philipp;
Wrede, Karsten H.;
Sure, Ulrich;
Jabbarli, Ramazan

Publication type:

Article

Machine learning-based differentiation between multiple sclerosis and glioma WHO II°-IV° using O-(2-[18F] fluoroethyl)-L-tyrosine positron emission tomography.

Published in:

Journal of Neuro-Oncology, 2021, v. 152, n. 2, p. 325, doi. 10.1007/s11060-021-03701-1

By:

Kebir, Sied;
Rauschenbach, Laurèl;
Weber, Manuel;
Lazaridis, Lazaros;
Schmidt, Teresa;
Keyvani, Kathy;
Schäfer, Niklas;
Milia, Asma;
Umutlu, Lale;
Pierscianek, Daniela;
Stuschke, Martin;
Forsting, Michael;
Sure, Ulrich;
Kleinschnitz, Christoph;
Antoch, Gerald;
Colletti, Patrick M.;
Rubello, Domenico;
Herrmann, Ken;
Herrlinger, Ulrich;
Scheffler, Björn

Publication type:

Article

Correction to: Global post‑marketing safety surveillance of Tumor Treating Fields (TTFields) in patients with high‑grade glioma in clinical practice.

Published in:

2021

By:

Shi, Wenyin;
Blumenthal, Deborah T.;
Bush, Nancy Ann Oberheim;
Kebir, Sied;
Lukas, Rimas V.;
Muragaki, Yoshihiro;
Zhu, Jay‑Jiguang;
Glas, Martin

Publication type:

Correction Notice

Global post-marketing safety surveillance of Tumor Treating Fields (TTFields) in patients with high-grade glioma in clinical practice.

Published in:

Journal of Neuro-Oncology, 2020, v. 148, n. 3, p. 489, doi. 10.1007/s11060-020-03540-6

By:

Shi, Wenyin;
Blumenthal, Deborah T.;
Oberheim Bush, Nancy Ann;
Kebir, Sied;
Lukas, Rimas V.;
Muragaki, Yoshihiro;
Zhu, Jay-Jiguang;
Glas, Martin

Publication type:

Article

Baseline T1 hyperintense and diffusion-restricted lesions are not linked to prolonged survival in bevacizumab-treated glioblastoma patients of the GLARIUS trial.

Published in:

Journal of Neuro-Oncology, 2019, v. 144, n. 3, p. 501, doi. 10.1007/s11060-019-03246-4

By:

Kebir, Sied;
Schaub, Christina;
Junold, Nina;
Hattingen, Elke;
Schäfer, Niklas;
Steinbach, Joachim P.;
Weyerbrock, Astrid;
Hau, Peter;
Goldbrunner, Roland;
Galldiks, Norbert;
Weller, Johannes;
Mack, Frederic;
Tzaridis, Theophilos;
Bähr, Oliver;
Seidel, Clemens;
Schlegel, Uwe;
Schmidt-Graf, Friederike;
Rohde, Veit;
Borchers, Christian;
Tabatabai, Ghazaleh

Publication type:

Article

Use of FET PET in glioblastoma patients undergoing neurooncological treatment including tumour-treating fields: initial experience.

Published in:

European Journal of Nuclear Medicine & Molecular Imaging, 2018, v. 45, n. 9, p. 1626, doi. 10.1007/s00259-018-3992-5

By:

Ceccon, Garry;
Lazaridis, Lazaros;
Stoffels, Gabriele;
Rapp, Marion;
Weber, Manuel;
Blau, Tobias;
Lohmann, Phillip;
Kebir, Sied;
Herrmann, Ken;
Fink, Gereon R.;
Langen, Karl-Josef;
Glas, Martin;
Galldiks, Norbert

Publication type:

Article

Diagnosis of pseudoprogression in patients with glioblastoma using O-(2-[F]fluoroethyl)- l-tyrosine PET.

Published in:

European Journal of Nuclear Medicine & Molecular Imaging, 2015, v. 42, n. 5, p. 685, doi. 10.1007/s00259-014-2959-4

By:

Galldiks, Norbert;
Dunkl, Veronika;
Stoffels, Gabriele;
Hutterer, Markus;
Rapp, Marion;
Sabel, Michael;
Reifenberger, Guido;
Kebir, Sied;
Dorn, Franziska;
Blau, Tobias;
Herrlinger, Ulrich;
Hau, Peter;
Ruge, Maximilian;
Kocher, Martin;
Goldbrunner, Roland;
Fink, Gereon;
Drzezga, Alexander;
Schmidt, Matthias;
Langen, Karl-Josef

Publication type:

Article

Blood-Based Biomarkers in High Grade Gliomas: a Systematic Review.

Published in:

Molecular Neurobiology, 2019, v. 56, n. 9, p. 6071, doi. 10.1007/s12035-019-1509-2

By:

Pierscianek, Daniela;
Ahmadipour, Yahya;
Oppong, Marvin Darkwah;
Rauschenbach, Laurèl;
Kebir, Sied;
Glas, Martin;
Sure, Ulrich;
Jabbarli, Ramazan

Publication type:

Article

Case Report: Pseudomeningeosis and Demyelinating Metastasis-Like Lesions From Checkpoint Inhibitor Therapy in Malignant Melanoma.

Published in:

Frontiers in Oncology, 2021, v. 11, p. N.PAG, doi. 10.3389/fonc.2021.637185

By:

Schmidt, Teresa;
Kebir, Sied;
Livingstone, Elisabeth;
Junker, Andreas;
Zülow, Stefan;
Lazaridis, Lazaros;
Oster, Christoph;
Chorti, Eleftheria;
Pierscianek, Daniela;
Pul, Refik;
Keyvani, Kathy;
Sure, Ulrich;
Stuschke, Martin;
Kleinschnitz, Christoph;
Scheffler, Björn;
Zimmer, Lisa;
Glas, Martin

Publication type:

Article

Tlr4 Deficiency Protects against Cardiac Pressure Overload Induced Hyperinflammation.

Published in:

PLoS ONE, 2015, v. 10, n. 11, p. 1, doi. 10.1371/journal.pone.0142921

By:

Ehrentraut, Heidi;
Felix Ehrentraut, Stefan;
Boehm, Olaf;
El Aissati, Sakina;
Foltz, Fabian;
Goelz, Lina;
Goertz, David;
Kebir, Sied;
Weisheit, Christina;
Wolf, Michael;
Meyer, Rainer;
Baumgarten, Georg

Publication type:

Article

Dosimetric impact of the positioning variation of tumor treating field electrodes in the PriCoTTF‐phase I/II trial.

Published in:

Journal of Applied Clinical Medical Physics, 2021, v. 22, n. 1, p. 242, doi. 10.1002/acm2.13144

By:

Nour, Youness;
Pöttgen, Christoph;
Kebir, Sied;
Lazaridis, Lazaros;
Lüdemann, Lutz;
Guberina, Maja;
Gauler, Thomas;
Scheffler, Björn;
Jabbarli, Ramazan;
Pierscianek, Daniela;
Sure, Ulrich;
Schmidt, Teresa;
Oster, Christoph;
Hau, Peter;
Glas, Martin;
Lübcke, Wolfgang;
Stuschke, Martin;
Guberina, Nika

Publication type:

Article

Precision neuro-oncology: a pilot analysis of personalized treatment in recurrent glioma.

Published in:

Journal of Cancer Research & Clinical Oncology, 2023, v. 149, n. 7, p. 3513, doi. 10.1007/s00432-022-04050-w

By:

Lazaridis, Lazaros;
Schmidt, Teresa;
Oster, Christoph;
Blau, Tobias;
Pierscianek, Daniela;
Siveke, Jens T.;
Bauer, Sebastian;
Schildhaus, Hans-Ulrich;
Sure, Ulrich;
Keyvani, Kathy;
Kleinschnitz, Christoph;
Stuschke, Martin;
Herrmann, Ken;
Deuschl, Cornelius;
Scheffler, Björn;
Kebir, Sied;
Glas, Martin

Publication type:

Article

Tumour Treating Fields (TTFields) in combination with lomustine and temozolomide in patients with newly diagnosed glioblastoma.

Published in:

Journal of Cancer Research & Clinical Oncology, 2020, v. 146, n. 3, p. 787, doi. 10.1007/s00432-019-03106-8

By:

Lazaridis, Lazaros;
Schäfer, Niklas;
Teuber-Hanselmann, Sarah;
Blau, Tobias;
Schmidt, Teresa;
Oster, Christoph;
Weller, Johannes;
Tzaridis, Theophilos;
Pierscianek, Daniela;
Keyvani, Kathy;
Kleinschnitz, Christoph;
Stuschke, Martin;
Scheffler, Björn;
Deuschl, Cornelius;
Sure, Ulrich;
Herrlinger, Ulrich;
Kebir, Sied;
Glas, Martin

Publication type:

Article

Regorafenib in patients with recurrent high-grade astrocytoma.

Published in:

Journal of Cancer Research & Clinical Oncology, 2019, v. 145, n. 4, p. 1037, doi. 10.1007/s00432-019-02868-5

By:

Kebir, Sied;
Rauschenbach, Laurel;
Radbruch, Alexander;
Lazaridis, Lazaros;
Schmidt, Teresa;
Stoppek, Ann-Kathrin;
Pierscianek, Daniela;
Stuschke, Martin;
Forsting, Michael;
Sure, Ulrich;
Keyvani, Kathy;
Kleinschnitz, Christoph;
Scheffler, Björn;
Glas, Martin

Publication type:

Article

Tumor growth patterns of MGMT-non-methylated glioblastoma in the randomized GLARIUS trial.

Published in:

Journal of Cancer Research & Clinical Oncology, 2018, v. 144, n. 8, p. 1581, doi. 10.1007/s00432-018-2671-z

By:

Schaub, Christina;
Kebir, Sied;
Junold, Nina;
Hattingen, Elke;
Schäfer, Niklas;
Steinbach, Joachim P.;
Weyerbrock, Astrid;
Hau, Peter;
Goldbrunner, Roland;
Niessen, Michael;
Mack, Frederic;
Stuplich, Moritz;
Tzaridis, Theophilos;
Bähr, Oliver;
Kortmann, Rolf-Dieter;
Schlegel, Uwe;
Schmidt-Graf, Friederike;
Rohde, Veit;
Braun, Christian;
Hänel, Mathias

Publication type:

Article

The earlier the better? Bevacizumab in the treatment of recurrent MGMT-non-methylated glioblastoma.

Published in:

Journal of Cancer Research & Clinical Oncology, 2016, v. 142, n. 8, p. 1825, doi. 10.1007/s00432-016-2187-3

By:

Schaub, Christina;
Schäfer, Niklas;
Mack, Frederic;
Stuplich, Moritz;
Kebir, Sied;
Niessen, Michael;
Tzaridis, Theophilos;
Banat, Mohammed;
Vatter, Hartmut;
Waha, Andreas;
Herrlinger, Ulrich;
Glas, Martin

Publication type:

Article

Phase I trial of dovitinib (TKI258) in recurrent glioblastoma.

Published in:

Journal of Cancer Research & Clinical Oncology, 2016, v. 142, n. 7, p. 1581, doi. 10.1007/s00432-016-2161-0

By:

Schäfer, Niklas;
Gielen, Gerrit;
Kebir, Sied;
Wieland, Anja;
Till, Andreas;
Mack, Frederic;
Schaub, Christina;
Tzaridis, Theophilos;
Reinartz, Roman;
Niessen, Michael;
Fimmers, Rolf;
Simon, Matthias;
Coch, Christoph;
Fuhrmann, Christine;
Herrlinger, Ulrich;
Scheffler, Björn;
Glas, Martin

Publication type:

Article

Tumor-associated hematopoietic stem and progenitor cells positively linked to glioblastoma progression.

Published in:

Nature Communications, 2021, v. 12, n. 1, p. 1, doi. 10.1038/s41467-021-23995-z

By:

Lu, I-Na;
Dobersalske, Celia;
Rauschenbach, Laurèl;
Teuber-Hanselmann, Sarah;
Steinbach, Anita;
Ullrich, Vivien;
Prasad, Shruthi;
Blau, Tobias;
Kebir, Sied;
Siveke, Jens T.;
Becker, Jürgen C.;
Sure, Ulrich;
Glas, Martin;
Scheffler, Björn;
Cima, Igor

Publication type:

Article

Depression in blepharospasm: a question of facial feedback?

Published in:

Neuropsychiatric Disease & Treatment, 2017, v. 13, p. 1861, doi. 10.2147/NDT.S141066

By:

Bedarf, Janis Rebecca;
Kebir, Sied;
Michelis, Joan Philipp;
Wabbels, Bettina;
Paus, Sebastian

Publication type:

Article

TLR2 stimulation induces cardiac inflammation but not cardiac depression in vivo.

Published in:

Journal of Inflammation, 2013, v. 10, n. 1, p. 1, doi. 10.1186/1476-9255-10-33

By:

Boehm, Olaf;
Knuefermann, Pascal;
Plueck, Johannes;
Schwederski, Markus;
Ehrentraut, Heidi;
Kebir, Sied;
Lohner, Ralph;
Velten, Markus;
Morath, Siegfried;
Koch, Alexander;
Zacharowski, Kai;
Grohé, Christian;
Hoeft, Andreas;
Baumgarten, Georg;
Meyer, Rainer

Publication type:

Article